{
    "2021-12-06": [
        [
            {
                "time": "",
                "original_text": "牧原股份11月份生猪销售收入67.67亿元、亿纬锂能实控人减持时误买入2万股，终止减持计划",
                "features": {
                    "keywords": [
                        "牧原股份",
                        "生猪销售",
                        "亿纬锂能",
                        "减持",
                        "误买入"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "农业",
                        "新能源"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "甘李药业研发管线再获海外关键性进展，抗糖尿病药物GZR18临床试验申请获美国FDA批准",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "GZR18",
                        "FDA",
                        "临床试验",
                        "糖尿病"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "国产胰岛素崛起在即，这一领域也将迎来爆发",
                "features": {
                    "keywords": [
                        "国产胰岛素",
                        "崛起",
                        "爆发"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "甘李药业（603087.SH）：GZR18获得美国FDA药品临床试验批准",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "GZR18",
                        "FDA",
                        "临床试验"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "甘李药业：美国子公司药品获FDA批准开展I期临床试验",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "FDA",
                        "I期临床试验",
                        "美国子公司"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "跨国药企占75%中国市场，国产胰岛素崛起",
                "features": {
                    "keywords": [
                        "跨国药企",
                        "中国市场",
                        "国产胰岛素",
                        "崛起"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}